GRI Bio, Inc.
GRI· Nasdaq
10-K due Feb 11 – Apr 1
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 6 filings.
Up after 2 of 10, down after 8.
GRI Bio, Inc. · CIK 1824293 · Engraved from SEC EDGAR
Based on 6 prior 10-K filings.
The stock’s move from the last close before each release to the first close after it, over the last 10 releases. Largest: −14.6% after Q3 2024.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.